U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H23N3O5S
Molecular Weight 393.457
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CGS-27023

SMILES

COC1=CC=C(C=C1)S(=O)(=O)N(CC2=CC=CN=C2)[C@H](C(C)C)C(=O)NO

InChI

InChIKey=BSIZUMJRKYHEBR-QGZVFWFLSA-N
InChI=1S/C18H23N3O5S/c1-13(2)17(18(22)20-23)21(12-14-5-4-10-19-11-14)27(24,25)16-8-6-15(26-3)7-9-16/h4-11,13,17,23H,12H2,1-3H3,(H,20,22)/t17-/m1/s1

HIDE SMILES / InChI

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
1.5 nM [IC50]
4.8 nM [IC50]
7.7 nM [IC50]
16.0 nM [IC50]
23.0 nM [IC50]
Name Type Language
CGS-27023
Code English
BUTANAMIDE, N-HYDROXY-2-(((4-METHOXYPHENYL)SULFONYL)(3-PYRIDINYLMETHYL)AMINO)-3-METHYL-, (2R)-
Systematic Name English
CGS-27023A FREE BASE
Code English
MMI-270B FREE BASE
Code English
MMI270B FREE BASE
Code English
Code System Code Type Description
PUBCHEM
446504
Created by admin on Sat Dec 16 13:42:45 GMT 2023 , Edited by admin on Sat Dec 16 13:42:45 GMT 2023
PRIMARY
CAS
161314-70-1
Created by admin on Sat Dec 16 13:42:45 GMT 2023 , Edited by admin on Sat Dec 16 13:42:45 GMT 2023
PRIMARY
FDA UNII
80AXY59IT2
Created by admin on Sat Dec 16 13:42:45 GMT 2023 , Edited by admin on Sat Dec 16 13:42:45 GMT 2023
PRIMARY
DRUG BANK
DB07556
Created by admin on Sat Dec 16 13:42:45 GMT 2023 , Edited by admin on Sat Dec 16 13:42:45 GMT 2023
PRIMARY